This randomized controlled trial aims to evaluate the efficacy of a combination of photo-biomodulation at acupuncture points, autologous platelet-rich plasma (PRP), and umbilical cord-derived exosome therapy in children with Autism Spectrum Disorder (ASD). The study will compare these interventions against standard care to determine their impact on the severity of autism symptoms, as measured by the Childhood Autism Rating Scale (CARS) and other related markers.
• Diagnosis of Autism Spectrum Disorder based on DSM-5 criteria
Age 3-12 years
Stable on current medications for at least 4 weeks prior to study entry
Parents or legal guardians willing to provide informed consent
• Severe comorbid medical conditions
Prior stem cell or exosome therapy
History of hypersensitivity to any component of the interventions
Inability to comply with study procedures